Long-acting injectable risperidone extends time to relapse

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2008

Schlagwörter:	Schizophrenia Risperidone Quetiapine Schizoaffective Disorder Injectable Formulation

Anmerkung:	© Adis International Ltd 2008

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1638(2008), 1 vom: Mai, Seite 9-10
Übergeordnetes Werk:	volume:1638 ; year:2008 ; number:1 ; month:05 ; pages:9-10

Links:	Volltext

DOI / URN:	10.2165/00128413-200816380-00018

Katalog-ID:	SPR035322217

Internformat


LEADER	01000caa a22002652 4500
001	SPR035322217
003	DE-627
005	20230519161844.0
007	cr uuu---uuuuu
008	201007s2008 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200816380-00018 \|2 doi
035			\|a (DE-627)SPR035322217
035			\|a (SPR)00128413-200816380-00018-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Long-acting injectable risperidone extends time to relapse
264		1	\|c 2008
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2008
650		4	\|a Schizophrenia \|7 (dpeaa)DE-He213
650		4	\|a Risperidone \|7 (dpeaa)DE-He213
650		4	\|a Quetiapine \|7 (dpeaa)DE-He213
650		4	\|a Schizoaffective Disorder \|7 (dpeaa)DE-He213
650		4	\|a Injectable Formulation \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1638(2008), 1 vom: Mai, Seite 9-10 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1638 \|g year:2008 \|g number:1 \|g month:05 \|g pages:9-10
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200816380-00018 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1638 \|j 2008 \|e 1 \|c 05 \|h 9-10

Indexfelder

matchkey_str	article:22306056:2008----::ogcignetbeiprdnetn
hierarchy_sort_str	2008
publishDate	2008
allfields	10.2165/00128413-200816380-00018 doi (DE-627)SPR035322217 (SPR)00128413-200816380-00018-e DE-627 ger DE-627 rakwb eng Long-acting injectable risperidone extends time to relapse 2008 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2008 Schizophrenia (dpeaa)DE-He213 Risperidone (dpeaa)DE-He213 Quetiapine (dpeaa)DE-He213 Schizoaffective Disorder (dpeaa)DE-He213 Injectable Formulation (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1638(2008), 1 vom: Mai, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1638 year:2008 number:1 month:05 pages:9-10 https://dx.doi.org/10.2165/00128413-200816380-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1638 2008 1 05 9-10
spelling	10.2165/00128413-200816380-00018 doi (DE-627)SPR035322217 (SPR)00128413-200816380-00018-e DE-627 ger DE-627 rakwb eng Long-acting injectable risperidone extends time to relapse 2008 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2008 Schizophrenia (dpeaa)DE-He213 Risperidone (dpeaa)DE-He213 Quetiapine (dpeaa)DE-He213 Schizoaffective Disorder (dpeaa)DE-He213 Injectable Formulation (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1638(2008), 1 vom: Mai, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1638 year:2008 number:1 month:05 pages:9-10 https://dx.doi.org/10.2165/00128413-200816380-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1638 2008 1 05 9-10
allfields_unstemmed	10.2165/00128413-200816380-00018 doi (DE-627)SPR035322217 (SPR)00128413-200816380-00018-e DE-627 ger DE-627 rakwb eng Long-acting injectable risperidone extends time to relapse 2008 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2008 Schizophrenia (dpeaa)DE-He213 Risperidone (dpeaa)DE-He213 Quetiapine (dpeaa)DE-He213 Schizoaffective Disorder (dpeaa)DE-He213 Injectable Formulation (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1638(2008), 1 vom: Mai, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1638 year:2008 number:1 month:05 pages:9-10 https://dx.doi.org/10.2165/00128413-200816380-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1638 2008 1 05 9-10
allfieldsGer	10.2165/00128413-200816380-00018 doi (DE-627)SPR035322217 (SPR)00128413-200816380-00018-e DE-627 ger DE-627 rakwb eng Long-acting injectable risperidone extends time to relapse 2008 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2008 Schizophrenia (dpeaa)DE-He213 Risperidone (dpeaa)DE-He213 Quetiapine (dpeaa)DE-He213 Schizoaffective Disorder (dpeaa)DE-He213 Injectable Formulation (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1638(2008), 1 vom: Mai, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1638 year:2008 number:1 month:05 pages:9-10 https://dx.doi.org/10.2165/00128413-200816380-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1638 2008 1 05 9-10
allfieldsSound	10.2165/00128413-200816380-00018 doi (DE-627)SPR035322217 (SPR)00128413-200816380-00018-e DE-627 ger DE-627 rakwb eng Long-acting injectable risperidone extends time to relapse 2008 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2008 Schizophrenia (dpeaa)DE-He213 Risperidone (dpeaa)DE-He213 Quetiapine (dpeaa)DE-He213 Schizoaffective Disorder (dpeaa)DE-He213 Injectable Formulation (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1638(2008), 1 vom: Mai, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1638 year:2008 number:1 month:05 pages:9-10 https://dx.doi.org/10.2165/00128413-200816380-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1638 2008 1 05 9-10
language	English
source	Enthalten in Inpharma weekly 1638(2008), 1 vom: Mai, Seite 9-10 volume:1638 year:2008 number:1 month:05 pages:9-10
sourceStr	Enthalten in Inpharma weekly 1638(2008), 1 vom: Mai, Seite 9-10 volume:1638 year:2008 number:1 month:05 pages:9-10
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Schizophrenia Risperidone Quetiapine Schizoaffective Disorder Injectable Formulation
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2008-05-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035322217
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035322217</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519161844.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2008 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200816380-00018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035322217</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200816380-00018-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Long-acting injectable risperidone extends time to relapse</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2008</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2008</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risperidone</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quetiapine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizoaffective Disorder</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Injectable Formulation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1638(2008), 1 vom: Mai, Seite 9-10</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1638</subfield><subfield code="g">year:2008</subfield><subfield code="g">number:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:9-10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200816380-00018</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1638</subfield><subfield code="j">2008</subfield><subfield code="e">1</subfield><subfield code="c">05</subfield><subfield code="h">9-10</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Long-acting injectable risperidone extends time to relapse Schizophrenia (dpeaa)DE-He213 Risperidone (dpeaa)DE-He213 Quetiapine (dpeaa)DE-He213 Schizoaffective Disorder (dpeaa)DE-He213 Injectable Formulation (dpeaa)DE-He213
topic	misc Schizophrenia misc Risperidone misc Quetiapine misc Schizoaffective Disorder misc Injectable Formulation
spellingShingle	misc Schizophrenia misc Risperidone misc Quetiapine misc Schizoaffective Disorder misc Injectable Formulation Long-acting injectable risperidone extends time to relapse
topic_unstemmed	misc Schizophrenia misc Risperidone misc Quetiapine misc Schizoaffective Disorder misc Injectable Formulation
topic_browse	misc Schizophrenia misc Risperidone misc Quetiapine misc Schizoaffective Disorder misc Injectable Formulation
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Long-acting injectable risperidone extends time to relapse
ctrlnum	(DE-627)SPR035322217 (SPR)00128413-200816380-00018-e
title_full	Long-acting injectable risperidone extends time to relapse
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2008
contenttype_str_mv	txt
container_start_page	9
container_volume	1638
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200816380-00018
title_sort	long-acting injectable risperidone extends time to relapse
title_auth	Long-acting injectable risperidone extends time to relapse
abstract	© Adis International Ltd 2008
abstractGer	© Adis International Ltd 2008
abstract_unstemmed	© Adis International Ltd 2008
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	Long-acting injectable risperidone extends time to relapse
url	https://dx.doi.org/10.2165/00128413-200816380-00018
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200816380-00018
up_date	2024-07-03T14:08:24.814Z
_version_	1803567187694190593
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035322217</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519161844.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2008 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200816380-00018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035322217</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200816380-00018-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Long-acting injectable risperidone extends time to relapse</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2008</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2008</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risperidone</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quetiapine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizoaffective Disorder</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Injectable Formulation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1638(2008), 1 vom: Mai, Seite 9-10</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1638</subfield><subfield code="g">year:2008</subfield><subfield code="g">number:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:9-10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200816380-00018</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1638</subfield><subfield code="j">2008</subfield><subfield code="e">1</subfield><subfield code="c">05</subfield><subfield code="h">9-10</subfield></datafield></record></collection>
score	7.399706

Nicht das Richtige dabei?

Schreiben Sie uns!

Long-acting injectable risperidone extends time to relapse

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?